Loading data
JBIONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 93.12 m USD | 53.19 m USD | 64.22 m USD | 38.62 m USD | 14.99 m USD |
| Operating profit | -113.54 m USD | -74.6 m USD | -81.41 m USD | -53.24 m USD | -23.02 m USD |
| Profit before tax | -127.35 m USD | -69.57 m USD | -75.47 m USD | -51.49 m USD | -22.96 m USD |
| Income tax expense | 58 k USD | 55 k USD | 56 k USD | 25 k USD | 3 k USD |
| Net income (reported basis) | -127.41 m USD | -69.63 m USD | -75.52 m USD | -51.51 m USD | -22.96 m USD |
| Net income attributable to common shareholders | -100.14 m USD | -69.63 m USD | -75.52 m USD | -51.51 m USD | -22.99 m USD |
| Basic earnings per share | -3.19 USD/share | -2.44 USD/share | -2.87 USD/share | -2.1 USD/share | -1.87 USD/share |
| Diluted earnings per share | -3.19 USD/share | -2.44 USD/share | -2.87 USD/share | -2.1 USD/share | -1.87 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.